A study on plasma prostaglandin E2 levels in hepatitis B carriers and patients with chronic active hepatitis.

about

A study on plasma prostaglandin E2 levels in hepatitis B carriers and patients with chronic active hepatitis.

Item

http://www.wikidata.org/entity/Q35948345

description

1987 nî lūn-bûn

@nan

1987年の論文

@ja

1987年論文

@yue

1987年論文

@zh-hant

1987年論文

@zh-hk

1987年論文

@zh-mo

1987年論文

@zh-tw

1987年论文

@wuu

1987年论文

@zh

1987年论文

@zh-cn

name

A study on plasma prostaglandi ...... with chronic active hepatitis.

@ast

A study on plasma prostaglandi ...... with chronic active hepatitis.

@en

type

Item

label

A study on plasma prostaglandi ...... with chronic active hepatitis.

@ast

A study on plasma prostaglandi ...... with chronic active hepatitis.

@en

prefLabel

A study on plasma prostaglandi ...... with chronic active hepatitis.

@ast

A study on plasma prostaglandi ...... with chronic active hepatitis.

@en

P1476

A study on plasma prostaglandi ...... with chronic active hepatitis.

@en

P2093

D G Kim

http://www.w3.org/2001/XMLSchema#string

D S Ahn

http://www.w3.org/2001/XMLSchema#string

J H Kim

http://www.w3.org/2001/XMLSchema#string

K Y Ahn

http://www.w3.org/2001/XMLSchema#string

Y G Lee

http://www.w3.org/2001/XMLSchema#string

Y S Heo

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function.

Radioimmunoassay measurement of prostaglandins E, A, and F in human plasma.

Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell

Prostaglandin E inhibits the production of human interleukin 2

Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation.

Prostaglandins and the modulation of immunological responses.

High-affinity binding sites for prostaglandin E on human lymphocytes.

Prostaglandin-producing suppressor cells in Hodgkin's disease.

Long term culture of tumour-specific cytotoxic T cells.

Enhancement of natural and antibody-dependent lymphocyte cytotoxicity by drugs which inhibit prostaglandin production by tumor target cells.

P304

170-175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3904/KJIM.1987.2.2.170

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1987-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20001120

http://www.w3.org/2001/XMLSchema#string

P698

3154830

http://www.w3.org/2001/XMLSchema#string

P932

4534930

http://www.w3.org/2001/XMLSchema#string